Adani Enterp. 2445.05↓-47.10(-1.89%)
Adani Ports 736.60↑4.55(0.62%)
Apollo Hospitals 4967.30↑153.05(3.18%)
Asian Paints 3237.25↓-3.45(-0.11%)
Axis Bank 926.10↑6.40(0.70%)
B P C L 360.05↓-4.50(-1.23%)
Bajaj Auto 4669.10↑25.50(0.55%)
Bajaj Finance 7023.90↓-16.60(-0.24%)
Bajaj Finserv 1457.25↑7.10(0.49%)
Bharti Airtel 836.50↑8.55(1.03%)
Britannia Inds. 4654.15↑18.90(0.41%)
Cipla 965.85↑1.10(0.11%)
Coal India 230.90↑0.55(0.24%)
Divi's Lab. 3511.60↓-13.80(-0.39%)
Dr Reddy's Labs 4610.45↑58.40(1.28%)
Eicher Motors 3699.40↓-16.65(-0.45%)
Grasim Inds 1710.55↑8.10(0.48%)
H D F C 2645.90↓-0.80(-0.03%)
HCL Technologies 1137.05↓-4.85(-0.42%)
HDFC Bank 1606.50↑2.50(0.16%)
HDFC Life Insur. 576.40↓-5.80(-1.00%)
Hero Motocorp 2892.65↑92.25(3.29%)
Hind. Unilever 2716.70↑18.80(0.70%)
Hindalco Inds. 420.75↑14.40(3.54%)
ICICI Bank 938.15↑2.05(0.22%)
IndusInd Bank 1288.20↓-1.95(-0.15%)
Infosys 1299.00↓-20.50(-1.55%)
ITC 443.40↑3.70(0.84%)
JSW Steel 706.60↑12.75(1.84%)
Kotak Mah. Bank 1938.75↑8.70(0.45%)
Larsen & Toubro 2234.55↑26.75(1.21%)
M & M 1341.40↑22.50(1.71%)
Maruti Suzuki 9485.35↑157.05(1.68%)
Nestle India 22046.45↑172.15(0.79%)
NTPC 174.55↑0.15(0.09%)
O N G C 154.70↑1.05(0.68%)
Power Grid Corpn 234.60↑1.60(0.69%)
Reliance Industr 2455.20↓-8.05(-0.33%)
SBI Life Insuran 1202.50↓-5.25(-0.43%)
St Bk of India 587.20↑4.45(0.76%)
Sun Pharma.Inds. 999.60↑11.90(1.20%)
Tata Consumer 796.05↑2.40(0.30%)
Tata Motors 535.90↑0.70(0.13%)
Tata Steel 108.00↑2.05(1.93%)
TCS 3305.60↓-18.40(-0.55%)
Tech Mahindra 1123.10↑2.30(0.21%)
Titan Company 2861.65↑34.40(1.22%)
UltraTech Cem. 7850.65↑7.85(0.10%)
UPL 683.35↑5.40(0.80%)
Wipro 404.95↓-2.20(-0.54%)

Bharat Biotech to collaborate with Hilleman to develop cholera vaccine

Hillchol was designed at the University of Gothenburg in Sweden and subsequently developed by Hilleman Labs

BS Reporter Hyderabad

Premium

Representative Image

2 min read Last Updated : Jun 26 2019 | 4:07 PM IST

Hilleman Laboratories announced on Wednesday that it will collaborate with Hyderabad-based vaccine maker Bharat Biotech International Limited (BBIL) for further development, manufacture and commercialisation of its next generation oral cholera vaccine, Hillchol.

Hillchol was designed at the University of Gothenburg in Sweden and subsequently developed by Hilleman Labs. The development process included demonstration of safety and imnmunogenicity in an age de-escalating phase I/II clinical trial conducted in Bangladesh.

For further development of the vaccine candidate, Hilleman Labs has entered into a licensing and manufacturing agreement with BBIL, which will scale the manufacturing process to commercial stage and establish product specifications required for WHO pre-qualification.